Send us a link

Subscribe to our newsletter

When It Comes to Covid-19, Most of Us Have Risk Exactly Backward

When It Comes to Covid-19, Most of Us Have Risk Exactly Backward

We aren't very good at discussing trade-offs, but we need to make some during this pandemic.

COVID-19 Can Wreck Your Heart, Even if You Haven't Had Any Symptoms

COVID-19 Can Wreck Your Heart, Even if You Haven't Had Any Symptoms

A growing body of research is raising concerns about the cardiac consequences of the coronavirus.

Vaccine Group Says 76 Rich Countries Now Committed to 'COVAX' Access Plan

Vaccine Group Says 76 Rich Countries Now Committed to 'COVAX' Access Plan

Seventy-six wealthy nations are now committed to joining a global COVID-19 vaccine allocation plan co-led by the World Health Organization (WHO) that aims to help buy and fairly distribute the shots, the project's co-lead said on Wednesday.

These Scientists Are Giving Themselves D.I.Y. Coronavirus Vaccines

These Scientists Are Giving Themselves D.I.Y. Coronavirus Vaccines

Impatient for a coronavirus vaccine, dozens of scientists around the world are giving themselves - and sometimes, friends and family - their own unproven versions.

More Testing Alone Will Not Get Us out of This Pandemic

More Testing Alone Will Not Get Us out of This Pandemic

Inequities and other social realities must be factored into diagnoses and tracing of COVID-19.

How the Race for a Covid-19 Vaccine is Getting Dirty

How the Race for a Covid-19 Vaccine is Getting Dirty

Scientists worldwide are working against the clock to find a viable coronavirus vaccine - but are corners being cut for the sake of political gain and profit?

Surveillance is underestimating the burden of the COVID-19 pandemic

Surveillance is underestimating the burden of the COVID-19 pandemic

So far in the COVID-19 pandemic, surveillance systems are not monitoring ill health and long-term implications of COVID-19, only deaths are reported.

Cities: Build Networks and Share Plans to Emerge Stronger from COVID-19

Cities: Build Networks and Share Plans to Emerge Stronger from COVID-19

Responses to the pandemic in India's slums, Brazil's favelas and Africa's marketplaces show that networks play a crucial part in making cities more resilient. Let's enhance and empower them.

Two Metres or One: What is the Evidence for Physical Distancing in Covid-19?

Two Metres or One: What is the Evidence for Physical Distancing in Covid-19?

Rigid safe distancing rules are an oversimplification based on outdated science and experiences of past viruses, publication argues.

Four Scenarios on How We Might Develop Immunity to Covid-19

Four Scenarios on How We Might Develop Immunity to Covid-19

As the world wearies of trying to suppress the SARS-CoV-2 virus, many of us are wondering what the future will look like as we try to learn to live with it.

Top US Virus Expert Warns on Fast-tracking Vaccine

Top US Virus Expert Warns on Fast-tracking Vaccine

US President Donald Trump reportedly is considering skipping regulatory steps to get out a vaccine.

Some People Can Get the Pandemic Virus Twice, a Study Suggests. That is No Reason to Panic

Some People Can Get the Pandemic Virus Twice, a Study Suggests. That is No Reason to Panic

A man in Hong Kong was found to be reinfected with COVID-19, but what that means for vaccines and immunity is unclear

Biogen Conference Likely Led to 20,000 COVID-19 Cases in Boston Area, Researchers Say

Biogen Conference Likely Led to 20,000 COVID-19 Cases in Boston Area, Researchers Say

A new study shows the Biogen conference held at Boston's Marriott Long Wharf hotel in February played a far greater role in spreading the coronavirus than previously thought.

Why the United States is Having a Coronavirus Data Crisis

Why the United States is Having a Coronavirus Data Crisis

Political meddling and years of neglect of public-health data management mean the country is flying blind.

Why Antibody Tests Won't Help You Much

Why Antibody Tests Won't Help You Much

Most antibody tests are useful only for large population surveys, diagnosis in certain children or when initial diagnostic testing fails, according to an expert panel.

FDA, Under Pressure, Authorizes Blood Plasma As Covid-19 Treatment

FDA, Under Pressure, Authorizes Blood Plasma As Covid-19 Treatment

The decision could generate intense controversy inside the administration and the broader scientific community because of a dearth of reliable data.

Trump administration bars FDA from regulating some laboratory tests, including for coronavirus

Trump administration bars FDA from regulating some laboratory tests, including for coronavirus

The Trump administration this week blocked the Food and Drug Administration from regulating a broad swath of laboratory tests, including for the coronavirus, in a move strongly opposed by the agency. The new policy stunned many health experts and laboratories because of its timing, several months into a pandemic.Some public health experts worry defective tests could end up on the market, but others cheer the change, saying it is long overdue.